References
- Agnoli C, Berrino F, Abagnato CA, et al (2010). Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis, 20, 41. https://doi.org/10.1016/j.numecd.2009.02.006
- American College of Radiology (1998). Breast imaging reporting and data system (BI-RADS). 3rd ed., American College of Radiology, Reston, VA.
- Bjorge T, Lukanova A, Jonsson H, et al (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev, 19, 1737-45. https://doi.org/10.1158/1055-9965.EPI-10-0230
- Bray F, Mc Carron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39. https://doi.org/10.1186/bcr932
- Breslow NE, Day NE (1980). Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. IARC Sci.Publ. 32. IARC, Lyon.
- Campagnoli C, Pasanisi P, Peris C, et al (2008). Insulin-like Growth Factor-I and Breast Cancer: Epidemiological and Clinical Data. In: Pasqualini JR (ed) Breast Cancer: Prognosis, Treatment and Prevention. 2nd ed. Informa Healthcare, New York.
- Campbell KL, Westerlind KC, Harber VJ, Friedenreich CM, Courneya KS (2005). Associations between aerobic fitness and estrogen metabolites in premenopausal women. Med Sci Sports Exerc, 37, 585-92. https://doi.org/10.1249/01.MSS.0000158185.23595.24
- Campbell KL, Westerlind KC, Harber VJ, et al (2007). Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev, 16, 731-9. https://doi.org/10.1158/1055-9965.EPI-06-0784
- Capasso I, Esposito E, Pentimalli F, et al (2011). Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther, 10, 1240-3.
- Carter JEL (2002). The Heath-Carter anthropometric somatotype- Instruction Manual. Surrey, Canada, TeP and Rosscraft.
- Cauley JA, Zmuda JM, Danielson ME, et al (2003). Estrogen metabolites and the risk of breast cancer in older women. Epidemiology, 14, 740-4. https://doi.org/10.1097/01.ede.0000091607.77374.74
- Chaudhuri PK, Chaudhuri B, Patel N (1986). Modulation of estrogen receptor by insulin and its biologic significance. Arch Surg, 121, 1322-5. https://doi.org/10.1001/archsurg.1986.01400110114019
- Connolly BS, Barnett C, Vogt KN, et al (2002). A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer, 44, 127-38. https://doi.org/10.1207/S15327914NC4402_02
- De Rose EH, Pigatto E, Celi R (1984). Kinanthropometry, physical education and sport training. SEED, Brasilia. (in Portuguese)
- De Stefani E, Ronco AL, Mendilaharsu M, Guidobono M, Deneo-Pellegrini H (1997a). Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol Biomark Prev, 6, 573-81.
- De Stefani E, Correa P, Ronco A, et al (1997b). Dietary fiber and risk of breast cancer. Nutr Cancer, 28, 14 9. https://doi.org/10.1080/01635589709514547
- De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, Ronco AL (1998). Essential fatty acids and breast cancer: a case-control study in Uruguay. Int J Cancer, 76, 491-4. https://doi.org/10.1002/(SICI)1097-0215(19980518)76:4<491::AID-IJC8>3.0.CO;2-M
- Falk RT, Fears T, Xu X, et al (2005). Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev, 14, 221-6.
- Faulkner J (1968). Physiology of swimming and diving. In Falls H: Exercise Physiology. Academic Press, Baltimore.
- Feig SA (1999). Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging. Semin Nucl Med, 29, 3-15. https://doi.org/10.1016/S0001-2998(99)80026-9
- Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10. Lyon, France: International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. [Accessed 17.08.2010].
- Food and Agricultural Organization (2010). http://faostat.fao. org/site/610/Desktop Default.aspx? PageID=610#ancor [Accessed 30.04.10].
- Freund E (1885). Diagnosis des Carcinomas. Wiener Medizinische, B1, 268 (in German).
- Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004). Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst, 96, 1152-60. https://doi.org/10.1093/jnci/djh216
- Glicksman AS, Rawson RW (1956). Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer, 9, 1127-34. https://doi.org/10.1002/1097-0142(195611/12)9:6<1127::AID-CNCR2820090610>3.0.CO;2-4
- Goodwin PJ, Ennis M, Pritchard KI, et al (2002). Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol, 20, 42-51. https://doi.org/10.1200/JCO.20.1.42
- Grote VA, Becker S, Kaaks R (2010). Diabetes mellitus type 2 - an independent risk factor for cancer? Exp Clin Endocrinol Diabetes, 118, 4-8. https://doi.org/10.1055/s-0029-1243193
- Guastamacchia E, Resta F, Mangia A, et al (2003). Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord, 3, 205-9. https://doi.org/10.2174/1568008033340199
- Hamelers IH, Steenbergh PH (2003). Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer, 10, 331- 45. https://doi.org/10.1677/erc.0.0100331
- Hanley AJ, Festa A, D'Agostino Jr RB, et al (2004). Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes, 53, 1773-81. https://doi.org/10.2337/diabetes.53.7.1773
- Hirose K, Toyama T, Iwata H, et al (2003). Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev, 4, 239-46.
- Jaumandreu S, Varas X, Mezzera J, et al (2001). Cytologic diagnosis in palpable nodules of the breast. Arch Ginecol Obstet, 39, 148-53 (in Spanish).
- Larsson SC, Mantzoros CS, Wolk A (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 121, 856-62. https://doi.org/10.1002/ijc.22717
- Macaulay VM (1992). Insulin-like growth factors and cancer. Br J Cancer, 65, 311-20. https://doi.org/10.1038/bjc.1992.65
- McTernan PG, Anderson LA, Anwar AJ, et al (2002). Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. J Clin Endocrinol Metab, 87, 1327-36. https://doi.org/10.1210/jc.87.3.1327
- Maiti B, Kundranda MN, Spiro TP, Daw HA (2010). The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat, 121, 479-83. https://doi.org/10.1007/s10549-009-0591-y
- Michels KB, Solomon CG, Hu FB, et al (2003). Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care, 26, 1752-8. https://doi.org/10.2337/diacare.26.6.1752
- Muck BR, Trotnow S, Hommel G (1975). Cancer of the breast, diabetes and pathological glucose tolerance. Arch Gynakol, 220, 73-81. https://doi.org/10.1007/BF00673150
- Muti P, Quattrin T, Grant BJ, et al (2002). Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev, 11, 1361-8.
- Novosyadlyy R, Lann DE, Vijayakumar A, et al (2010). Insulinmediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res, 70, 741-51. https://doi.org/10.1158/0008-5472.CAN-09-2141
- Parkin DM, Whelan SL, Ferlay J, et al (2002). Cancer incidence in five continents, vol 8. IARC Scientific Publications No. 155, IARC, Lyon.
- Pasanisi P, Berrino F, De Petris M, et al (2006). Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer, 119, 236-8. https://doi.org/10.1002/ijc.21812
- Potischman N, McCulloch CE, Byers T, et al (1991). Associations between breast cancer, plasma triglycerides, and cholesterol. Nutr Cancer, 15, 205-15. https://doi.org/10.1080/01635589109514128
- Reaven GM (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-607. https://doi.org/10.2337/diabetes.37.12.1595
- Rock CL, Demark-Wahnefried W (2002). Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr, 132, 3504-7S. https://doi.org/10.1093/jn/132.11.3504S
- Ronco AL, De Stefani E, Mendilaharsu M, Deneo-Pellegrini H (1996). Meat, fat and the risk of breast cancer: a case-control study from Uruguay. Int J Cancer, 65, 328-31. https://doi.org/10.1002/(SICI)1097-0215(19960126)65:3<328::AID-IJC9>3.0.CO;2-1
- Ronco AL, De Stefani E, Boffetta P, et al (1999). Vegetables, fruits, and related nutrients and risk of breast cancer: a case control study in Uruguay. Nutr Cancer, 35, 111-9. https://doi.org/10.1207/S15327914NC352_3
- Ronco AL, De Stefani E, Boffetta P, et al (1999). Vegetables, fruits, and related nutrients and risk of breast cancer: a case control study in Uruguay. Nutr Cancer, 35, 111-9. https://doi.org/10.1207/S15327914NC352_3
- Ronco AL, De Stefani E, Fabra A (2003). White meat intake and the risk of breast cancer: a case-control study in Montevideo, Uruguay. Nutr Res, 23, 151-62. https://doi.org/10.1016/S0271-5317(02)00496-7
- Ronco AL, De Stefani E, Boffetta P, et al (2006). Food patterns and risk of breast cancer: A factor analysis study in Uruguay. Int J Cancer, 19, 1672-8.
- Ronco AL, Silveira S, De Stéfani E, Deneo-Pellegrini H, Mendilaharsu M (2007). Factores socioculturales y psicologicos y cancer de mama: un estudio caso-control en Montevideo, Uruguay. Biomedicina, 3, 6-17.
- Ronco AL, Mendoza B, Varas X, et al (2008). Somatotype and risk of breast cancer: a case-control study in Uruguay. Braz J Epidemiol, 11, 215-27. https://doi.org/10.1590/S1415-790X2008000200004
- Ronco AL, Boeing H, De Stefani E, et al (2009a). A case-control study on fat to muscle ratio and risk of breast cancer. Nutr Cancer, 61, 466-74. https://doi.org/10.1080/01635580902725995
- Ronco AL, Stoll M, De Stefani E et al (2009b). Rh factor, family history and risk of breast cancer: a case-control study in Uruguay. Cancer Det Prev, 32, 277-85. https://doi.org/10.1016/j.cdp.2008.12.005
- Ronco AL, De Stefani E, Aune D, et al (2010a). Nutrient patterns and risk of breast cancer in Uruguay. Asian Pac J Cancer Prev, 11, 519-24.
- Ronco AL, De Stefani E, Stoll M (2010b). Hormonal and metabolic modulation through nutrition: towards a primary prevention of breast cancer. The Breast, 19, 322-32. https://doi.org/10.1016/j.breast.2010.05.005
- Ronco AL, De Stefani E, Deneo-Pellegrini H, et al (2010c). Dietary patterns and risk of ductal carcinoma of the breast: a factor analysis in Uruguay. Asian Pac J Cancer Prev, 11, 1187-93.
- Ronco AL, De Stefani E (2010d). Diabetes, overweight and risk of breast cancer: a case-control study in Uruguay. Proceedings of the XVI World Congress of the Senologic International Society. Valencia, Spain, October 20-22nd, 2010.
- Rosato V, Bosetti C, Talamini R, et al (2011). Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol, 22, 2687-92. https://doi.org/10.1093/annonc/mdr025
- Sachdev D, Yee D (2001). The IGF system and breast cancer. Endocr Relat Cancer, 8, 197-209. https://doi.org/10.1677/erc.0.0080197
- Schott S, Schneeweiss A, Sohn C (2010). Breast cancer and diabetes mellitus. Exp Clin Endocrinol Diabetes, 118, 673-7. https://doi.org/10.1055/s-0030-1254116
- Sinagra D, Amato C, Scarpilta AM, et al (2002). Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci, 6, 55-9.
- Soler M, Chatenoud L, Negri E, et al (1999). Hypertension and hormone related neoplasms in women. Hypertension, 34, 320-5. https://doi.org/10.1161/01.HYP.34.2.320
- Tsugane S, Inoue M (2010). Insulin resistance and cancer: epidemiological evidence. Cancer Sci, 101, 1073-9. https://doi.org/10.1111/j.1349-7006.2010.01521.x
- United Nations Organization (2009), Human development index rankings. Available at: http://hdr.undp.org/en/statistics/. [accessed 27.04.10].
- U.S. Census Bureau (2010). International data base, http://www. census.gov/ipc/www/idb/ country.php [accessed 30.04.10].
- Varas X, Leborgne F, Leborgne JH (1992). Non palpable, probably benign lesions: role of follow-up mammography. Radiology, 184, 1409-14.
- Verheus M, Peeters PH, Rinaldi S, et al (2006). Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer, 119, 659-67. https://doi.org/10.1002/ijc.21861
- Vona-Davis L, Howard-McNatt M, Rose DP (2007). Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev, 8, 395-408. https://doi.org/10.1111/j.1467-789X.2007.00396.x
- Warburg O (1930). The metabolism of tumors. Constable Press, London.
- Westerlind KC, Williams NI (2007). Effect of energy deficiency on estrogen metabolism in premenopausal women. Med Sci Sports Exerc, 39, 1090-7.
- Wilson AM, Ryan MC, Boyle AJ (2006). The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol, 106, 291-7. https://doi.org/10.1016/j.ijcard.2005.01.068
- World Cancer Research Fund/American Institute for Cancer Research (2007). Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC.
- Xue F, Michels KB (2007). Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr, 86, 823-35. https://doi.org/10.1093/ajcn/86.3.823S
Cited by
- Hypertension and the Risk of Breast Cancer in Chilean Women: a Case-control Study vol.13, pp.11, 2012, https://doi.org/10.7314/APJCP.2012.13.11.5829
- Diabetes increases the risk of breast cancer: a meta-analysis vol.19, pp.6, 2012, https://doi.org/10.1530/ERC-12-0242
- Repercussions of Breastfeeding by Diabetic Women for Breast Cancer vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6233
- Prevalence of the Metabolic Syndrome and Associated Factors in Korean Cancer Survivors vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1773
- Vascular Endothelial Growth Factor (VEGF) Gene Polymorphisms and Breast Cancer Risk in a Chinese Population vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2433
- Type 2 Diabetes Mellitus, Oral Diabetic Medications, Insulin Therapy, and Overall Breast Cancer Risk vol.2013, pp.2090-4649, 2013, https://doi.org/10.1155/2013/181240
- Association of Polymorphisms in Stress-Related TNFα and NPY Genes with the Metabolic Syndrome in Han and Hui Ethnic Groups vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5895
- Breast Cancer in Tunisia: Association of Body Mass Index with Histopathological Aspects of Tumors vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6805
- Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India vol.35, pp.11, 2014, https://doi.org/10.1007/s13277-014-2404-0
- Metabolic Syndrome and Breast Cancer Risk: A Case-Cohort Study Nested in a Multicentre Italian Cohort vol.10, pp.6, 2015, https://doi.org/10.1371/journal.pone.0128891
- β-Adrenergic Receptors : New Target in Breast Cancer vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8031
- Risk factors of breast cancer and knowledge about the disease: an integrative revision of Latin American studies vol.22, pp.1, 2017, https://doi.org/10.1590/1413-81232017221.09272015
- The Effect of Insulin Resistance on Breast Cancer Risk in Latinas of Mexican Origin vol.12, pp.9, 2014, https://doi.org/10.1089/met.2014.0071
- Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective vol.6, pp.6, 2015, https://doi.org/10.3945/an.115.009647